Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lene Dreyer

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
RMD Open|April 20, 2025
Cancer recurrence risk with bDMARD treatment in patients with rheumatoid arthritis and a history of cancer: a nationwide Danish register-based cohort studyRasmus Westermann, René Cordtz, Kirsten Duch, et al.
Rheumatology (Oxford, England)|April 24, 2024
Temporal trends in mortality in patients with systemic lupus erythematosus: a Danish population-based matched cohort studySalome Kristensen, Kirsten Duch, Bolette Gylden Soussi, et al.
Clinical Rheumatology|March 7, 2021
Patient-controlled outpatient follow-up on demand for patients with rheumatoid arthritis: a 2-year randomized controlled trialRené Panduro Poggenborg, Ole Rintek Madsen, Anne-Marie Tetsche Sweeney, et al.
Rheumatology (Oxford, England)|March 7, 2024
Cancer risk with tocilizumab/sarilumab, abatacept and rituximab treatment in patients with rheumatoid arthritis: a Danish cohort studyRasmus Westermann, René Lindholm Cordtz, Kirsten Duch, et al.
Rheumatology (Oxford, England)|December 28, 2018
Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based studyKristian Zobbe, Daniel Prieto-Alhambra, René Cordtz, et al.
Annals of the Rheumatic Diseases|December 9, 2017
Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort studyLene Dreyer, René L Cordtz, Inger Marie J Hansen, et al.
Clinical Rheumatology|May 27, 2016
How do women with lupus manage fatigue? A focus group studyAnne Ørnholt Kier, Julie Midtgaard, Karin Sørig Hougaard, et al.
BMJ Open|July 12, 2019
Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)Line Uhrenholt, Annette Schlemmer, Ellen-Margrethe Hauge, et al.
Pain|January 30, 2007
Computerized cuff pressure algometry: A new method to assess deep-tissue hypersensitivity in fibromyalgiaAnders Jespersen, Lene Dreyer, Sally Kendall, et al.
Rheumatology (Oxford, England)|June 13, 2018
Gender differences in biologic treatment outcomes-a study of 1750 patients with psoriatic arthritis using Danish Health Care RegistersPil Højgaard, Christine Ballegaard, René Cordtz, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
RMD Open|April 20, 2025
Cancer recurrence risk with bDMARD treatment in patients with rheumatoid arthritis and a history of cancer: a nationwide Danish register-based cohort studyRasmus Westermann, René Cordtz, Kirsten Duch, et al.
Rheumatology (Oxford, England)|April 24, 2024
Temporal trends in mortality in patients with systemic lupus erythematosus: a Danish population-based matched cohort studySalome Kristensen, Kirsten Duch, Bolette Gylden Soussi, et al.
Clinical Rheumatology|March 7, 2021
Patient-controlled outpatient follow-up on demand for patients with rheumatoid arthritis: a 2-year randomized controlled trialRené Panduro Poggenborg, Ole Rintek Madsen, Anne-Marie Tetsche Sweeney, et al.
Rheumatology (Oxford, England)|March 7, 2024
Cancer risk with tocilizumab/sarilumab, abatacept and rituximab treatment in patients with rheumatoid arthritis: a Danish cohort studyRasmus Westermann, René Lindholm Cordtz, Kirsten Duch, et al.
Rheumatology (Oxford, England)|December 28, 2018
Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based studyKristian Zobbe, Daniel Prieto-Alhambra, René Cordtz, et al.
Annals of the Rheumatic Diseases|December 9, 2017
Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort studyLene Dreyer, René L Cordtz, Inger Marie J Hansen, et al.
Clinical Rheumatology|May 27, 2016
How do women with lupus manage fatigue? A focus group studyAnne Ørnholt Kier, Julie Midtgaard, Karin Sørig Hougaard, et al.
BMJ Open|July 12, 2019
Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)Line Uhrenholt, Annette Schlemmer, Ellen-Margrethe Hauge, et al.
Pain|January 30, 2007
Computerized cuff pressure algometry: A new method to assess deep-tissue hypersensitivity in fibromyalgiaAnders Jespersen, Lene Dreyer, Sally Kendall, et al.
Rheumatology (Oxford, England)|June 13, 2018
Gender differences in biologic treatment outcomes-a study of 1750 patients with psoriatic arthritis using Danish Health Care RegistersPil Højgaard, Christine Ballegaard, René Cordtz, et al.
Pageof 13